COVID-19 Pandemic Hampering Launch of New Oncology Trials
A team of researchers conducted a study to assess the impact of the COVID-19 pandemic on the initiation of clinical trials in oncology.
General Oncology
Preexisting Autoimmune Disease Increases Incidence of irAEs With PD-1 Immunotherapy for Advanced Cancer
Study findings demonstrate the rates of immune-related adverse events and flares of the underlying disorders in this patient population.
Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization
The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.
New Guidelines Help Decision Making for the Prevention, Management of Venous Thromboembolism
The American Society of Hematology released guidelines for preventing and managing venous thromboembolism in patients with cancer.
Risk Factors Associated With Chemotherapy-Induced Peripheral Neuropathy
Researchers identified the risk factors for chemotherapy-induced peripheral neuropathy in cancer patients treated with paclitaxel or oxaliplatin.
Self-Care With Telephone Support Effectively Improved Depression Symptoms in Cancer Survivors
Researchers conducted a randomized superiority trial to determine if a telephone-directed self-care intervention more effectively reduced depressive symptoms in cancer survivors compared with usual care alone.
Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer
This fact sheet reviews the current guidelines for coronavirus disease 2019 (COVID-19) vaccination in patients with cancer.
ASCO Publishes 2021 Report on Progress Against Cancer
The American Society of Clinical Oncology (ASCO) highlights the past year’s oncologic advances and identifies important areas for future research in its 2021.
Neurologic Sequelae Associated With SARS-CoV-2 Infection in Patients With Cancer
Researchers at Memorial Sloan Kettering Cancer Center investigated the incidence of neurologic sequelae of COVID-19 in patients with cancer.
Underlying Medical Conditions Make Cancer Survivors Particularly Vulnerable to Severe COVID-19 Illness
The NHIS identified underlying medical conditions common among cancer survivors, prompting the ACS to recommend prioritizing them to receive the COVID-19 vaccine.
-
Loading...
-
Loading...
Next post in General Oncology
